Who owns Dare Bioscience?
- Ticker: DARE
- CUSIP Number: 23666p101
Tip: Access positions for across all investors
Analyze quarterly positions in Dare Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Dare Bioscience stock
Who bought or sold Dare Bioscience this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 3.5M | $1.7M | 0% | Mar 2024 |
|
| Geode Capital Management | 989k | $485k | 21% | Mar 2024 |
|
| BlackRock | 396k | $194k | -2% | Mar 2024 |
|
| Northern Trust | 183k | $90k | 14% | Mar 2024 |
|
| Citadel Advisors | 161k | $79k | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 126k | $62k | 0% | Mar 2024 |
|
| Founders Financial Securities | 124k | $61k | 0% | Mar 2024 |
|
| Commonwealth Equity Services | 46k | $23k | 41% | Mar 2024 |
|
| Two Sigma Securities | 33k | $16k | 100% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 31k | $15k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 31k | $15k | 0% | Mar 2024 |
|
| XTX Topco | 28k | $14k | 100% | Mar 2024 |
|
| Objectivity Squared | 27k | $13k | 170% | Mar 2024 |
|
| Susquehanna International | 26k | $13k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 23k | $11k | -15% | Mar 2024 |
|
| Tower Research Capital | 20k | $9.9k | -1% | Mar 2024 |
|
| Advisor Group Holdings | 20k | $9.8k | 900% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 20k | $9.8k | -28% | Mar 2024 |
|
| Advisory Services Network | 15k | $7.4k | 0% | Mar 2024 |
|
| First Affirmative Financial Network | 12k | $6.0k | 10% | Mar 2024 |
|
| Jane Street | 12k | $5.8k | 100% | Mar 2024 |
|
| IFS Advisors | 11k | $5.6k | 0% | Mar 2024 |
|
| HighTower Advisors | 11k | $5.0k | -77% | Mar 2024 |
|
| First Pacific Financial | 10k | $4.9k | 0% | Mar 2024 |
|
| Pnc Financial Services | 4.4k | $2.2k | 0% | Mar 2024 |
|
| FMR | 1.1k | $527.024800 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 771.00 | $378.021300 | 2% | Mar 2024 |
|
| UBS Group | 500.00 | $245.000000 | -94% | Mar 2024 |
|
| Jpmorgan Chase & Co | 239.00 | $116.990500 | -98% | Mar 2024 |
|
| Capital Advisors | 204.00 | $0 | 100% | Mar 2024 |
|
| Caldwell Sutter Capital | 200.00 | $98.000000 | 0% | Mar 2024 |
|
| Bank of America Corporation | 146.00 | $72.007200 | -47% | Mar 2024 |
|
| Cornerstone Planning Group | 16.00 | $5.000000 | 0% | Mar 2024 |
|
| Goss Wealth Management | 10.00 | $5.000000 | 100% | Mar 2024 |
|
Who sold out of Dare Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Sep 2023 | 6.5M | $3.0M |
| Visionary Horizons | Dec 2023 | 37k | $12k |
| Asset Management Investors | Dec 2023 | 23k | $7.1k |
| Virtu Financial | Dec 2023 | 14k | $4.0k |
| Morgan Stanley | Sep 2023 | 2.6k | $1.2k |
| Royal Bank of Canada | Dec 2023 | 535.00 | $0 |
| Life Planning Partners | Dec 2023 | 385.00 | $119.003500 |